investingreview.org logo
Vermeiden Sie Betrug, informieren Sie sich und finden Sie das Beste
Nothings Found.

Investment Insights: Nichols & Pratt Advisers LLP Show Strong Holdings in Q4 2022

Ava Hoppe | 1 May, 2023

Nichols & Pratt Advisers LLP, a Boston based investment advisory firm, has recently released their quarterly 13F filings for the Q3 2022 and Q4 2022 periods. These reports indicate significant changes in the shares and value of the funds held across multiple companies.

The total value of shares held by Nichols & Pratt Advisers LLP increased from $1.8 billion in the Q3 to $1.9 billion in the Q4 period, marking a 4.9% increase. The fund made interesting moves in the stock market, increasing their holdings in some companies, while reducing them in others.

One of the key contributors to the rise in value was Johnson & Johnson (JNJ). The company witnessed a slight reduction in the number of shares held by Nichols & Pratt Advisers LLP from 529,933 shares in Q3 to 527,405 in Q4, but its value increased by 7.7%. Nichols & Pratt Advisers LLP also increased their holdings in some companies, including PepsiCo Inc (PEP), Novo Nordisk AS Sponsored ADR (NVO), and McCormick & Co Inc (MKC).

On the other hand, the fund reduced its holdings in popular companies like Amazon.com Inc (AMZN), Apple Inc (AAPL), and Intel Corp (INTC). Amazon.com Inc bore the brunt of these reductions, with a 24.8% fall in its value, despite its share prices soaring in the Q4 period.

Another company of note is Berkshire Hathaway Inc-CL B (BRK-B), with Nichols & Pratt Advisers LLP increasing their shares in the company. It was good news for the diversified holding company, as the value of shares increased by 17% during the Q4 period.

Other significant moves in the stock market include the reduction of holdings in The Walt Disney Co (DIS) and Starbucks Corp (SBUX), with values dipping by 35.5% and 6.7% respectively. Also, Nichols & Pratt Advisers LLP added to their holdings in newly-formed Warner Bros Discovery Inc-CL A (WBD) and pharma giant AbbVie Inc (ABBV).

Conclusion

Nichols & Pratt Advisers LLP has demonstrated a strategic approach to holding and trading in the stock market in the Q4 2022 period. The fund's ability to capitalize on the ever-changing market conditions has seen them increase value across different industries. Although some companies observed a decrease in value, the overall result is quite optimistic, and the fund's diverse holdings should set them up for a successful 2023.

Viele Menschen wurden durch Betrug und Ponzi-Vorhaben verbrannt. Deshalb haben wir diese Website erstellt, um Ihnen als potenziellem Investor dabei zu helfen, die Fakten zu ermitteln, die besten zu finden und Betrugs- und Ponzi-Vorhaben zu vermeiden.

Alle auf dieser Website bereitgestellten Informationen werden ohne Gewähr und nur zu Informationszwecken bereitgestellt.
InvestingReview.org bietet keine Anlageberatung an. InvestingReview.org ist kein Anlageberater und wird von keiner US-amerikanischen oder nicht US-amerikanischen Aufsichtsbehörde unterstützt oder ist mit dieser verbunden.


Kürzlich gesuchte Firmen

Bitte beachten Sie: Die Suchdaten werden von Dritten gesammelt und einmal täglich aktualisiert.

Copyright © 2023 by InvestingReview.org / Alle Rechte vorbehalten.